More Globe Newswire

View Older Stories View Newer Stories

Mar 2, 2026 07:02AM Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
Mar 2, 2026 07:00AM Independent Proxy Advisory Firms Recommend Titanium Shareholders Vote "FOR" the Previously-Announced Going-Private Transaction
Mar 2, 2026 07:00AM Loblaw® and Flashfood helped Canadians save $58 million on groceries in 2025
Mar 2, 2026 07:00AM Anfield Energy Announces Shareholder Approval at Special Shareholder Meeting of Uranium Energy Corp. as a Control Person
Mar 2, 2026 07:00AM Drilling at Juby Gold Project Intersects 95.4 metres(m) at 1.36 g/t gold
Mar 2, 2026 07:00AM Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Upcoming Institutional Investor Conferences
Mar 2, 2026 07:00AM uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Mar 2, 2026 07:00AM OLLY Brings Mood-Transforming Body Wash to Canada
Mar 2, 2026 07:00AM Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
Mar 2, 2026 07:00AM U.S. Defense Logistics Agency Awards Historic Contract to REalloys’ Terves LLC to Scale Domestic Rare Earth Metal Production
Mar 2, 2026 07:00AM Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Mar 2, 2026 07:00AM Beyond Binary: Qubic’s Neuraxon 2.0 Introduces a Trinary Architecture for Continuous, Adaptive AI Systems
Mar 2, 2026 07:00AM Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
Mar 2, 2026 07:00AM Kaspi.kz 4Q & FY 2025 Financial Results
Mar 2, 2026 07:00AM ISC to Release Financial Results for the Three Months and Year Ended 2025 on March 19, 2026
Mar 2, 2026 07:00AM Westhaven Appoints Senior Leaders in Indigenous, Community Relations and Permitting
Mar 2, 2026 07:00AM EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema
Mar 2, 2026 07:00AM NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
Mar 2, 2026 07:00AM Cielo Closes Private Placement Financing Previously Announced in Connection with Strategic Asset Acquisition
Mar 2, 2026 07:00AM 25% of Americans expect streaming discounts for binge-watching shows
Mar 2, 2026 07:00AM Intuitive Expands Investment and Footprint in Europe
Mar 2, 2026 07:00AM Kaspi.kz 4Q & FY 2025 Financial Results
Mar 2, 2026 07:00AM Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement
Mar 2, 2026 07:00AM Fueled by U.S. Success, GEEK BAR Launches SPARK to Lead a New Era in Europe
Mar 2, 2026 07:00AM SPARC AI Appoints Matt McCrann as U.S. CEO
Mar 2, 2026 07:00AM NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
Mar 2, 2026 07:00AM GT Biopharma Reports Full Year 2025 Financial Results
Mar 2, 2026 07:00AM Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Mar 2, 2026 07:00AM Hain Celestial Completes Sale of North American Snacks Business
Mar 2, 2026 07:00AM MapLight Therapeutics to Participate in Upcoming Investor Conferences
Mar 2, 2026 07:00AM ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
Mar 2, 2026 07:00AM Digital Realty Enters Bulgaria with Acquisition of Highly Connected Interconnection Hub in Sofia
Mar 2, 2026 07:00AM Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Mar 2, 2026 07:00AM Due Diligence in Action: 1,000 Serious Supply Chain Issues Uncovered Weekly with SMETA
Mar 2, 2026 07:00AM Tecnoglass to Attend the Raymond James 47th Annual Institutional Investors Conference
Mar 2, 2026 07:00AM Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 2, 2026 07:00AM Aspo completes the divestment of Leipurin to Lantmännen
Mar 2, 2026 07:00AM Signify share repurchase periodic update
Mar 2, 2026 07:00AM YAROOMS Introduces Yarvis: Not an App. A Colleague.
Mar 2, 2026 06:55AM YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
Mar 2, 2026 06:55AM CTO Realty Growth Announces Acquisition of Palms Crossing for $81.6 Million
Mar 2, 2026 06:55AM ADT Reports Fourth Quarter and Full Year 2025 Results; Announces New $1.5 Billion Share Repurchase Authorization
Mar 2, 2026 06:54AM CSG Enters the Hungarian Defence Industry. To Participate in the Delivery of Thousands of Military Vehicles; Investment Plans Also Include Integration of HIMARS Systems at Rába
Mar 2, 2026 06:50AM Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Mar 2, 2026 06:50AM Endeavour Silver Announces Board and Management Updates
Mar 2, 2026 06:47AM Webcast via Investor Meet Company Platform
Mar 2, 2026 06:45AM Stovex Global Deepens Strategic Cooperation, Investing $5 Million in Dedicated Funds to Support Casder Vanguard AI 5.0 Live Testing and System Upgrades
Mar 2, 2026 06:42AM WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE GOLD 3X DAILY SHORT SECURITIES ISIN: IE00B6X4BP29
Mar 2, 2026 06:30AM Azimut Reports AGM Results and Provides Drilling Update
Mar 2, 2026 06:30AM Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
View Newer Stories View Older Stories